The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 20, 2016

Filed:

Nov. 19, 2010
Applicants:

Richard R. Bott, Burlingame, CA (US);

Thijs Kaper, Half Moon Bay, CA (US);

Bradley Kelemen, Menlo Park, CA (US);

Frits Goedegebuur, Vlaardingen, NL;

Ronaldus Wilhelmus Hommes, Haarlem, NL;

Slavko Kralj, Oestgeest, NL;

Paulien Kruithof, Zoetmeer, NL;

Igor Nikolaev, Noordwijk, NL;

Wilhelmus Antonious Hendricus Van Der Kley, The Hague, NL;

Johannes Franciscus Thomas Van Lieshout, Utrecht, NL;

Sander Van Stigt Thans, Zevenbergen, NL;

Gudrun Vogtentanz, Sunnyvale, CA (US);

Mats Sandgren, Uppsala, SE;

Inventors:

Richard R. Bott, Burlingame, CA (US);

Thijs Kaper, Half Moon Bay, CA (US);

Bradley Kelemen, Menlo Park, CA (US);

Frits Goedegebuur, Vlaardingen, NL;

Ronaldus Wilhelmus Hommes, Haarlem, NL;

Slavko Kralj, Oestgeest, NL;

Paulien Kruithof, Zoetmeer, NL;

Igor Nikolaev, Noordwijk, NL;

Wilhelmus Antonious Hendricus Van Der Kley, The Hague, NL;

Johannes Franciscus Thomas Van Lieshout, Utrecht, NL;

Sander Van Stigt Thans, Zevenbergen, NL;

Gudrun Vogtentanz, Sunnyvale, CA (US);

Mats Sandgren, Uppsala, SE;

Assignee:

DANISCO US INC., Palo Alto, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/47 (2006.01); C12N 9/42 (2006.01); C12N 1/20 (2006.01); C12N 15/00 (2006.01); C07H 21/04 (2006.01);
U.S. Cl.
CPC ...
C12N 9/2445 (2013.01); C12Y 302/01021 (2013.01);
Abstract

The present disclosure is generally directed to enzymes and in particular beta-glucosidase variants. Also described are nucleic acids encoding beta-glucosidase variants, compositions comprising beta-glucosidase variants, methods of using beta-glucosidase variants, and methods of identifying additional useful beta-glucosidase variants.


Find Patent Forward Citations

Loading…